Viewing Study NCT00006066


Ignite Creation Date: 2025-12-24 @ 4:40 PM
Ignite Modification Date: 2026-02-20 @ 6:25 PM
Study NCT ID: NCT00006066
Status: COMPLETED
Last Update Posted: 2021-11-01
First Post: 2000-07-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Injections, Subcutaneous View
None Interleukin-2 View
None Dose-Response Relationship, Drug View
None Drug Therapy, Combination View
None Immunocompromised Host View
None CD4 Lymphocyte Count View
None Anti-HIV Agents View